Common autoimmune drugs reduce mortality, up clinical status in COVID-19: NIH
By
Alicia Lasek (f3)
Jun 06, 2022
Two commonly used autoimmune drugs could be used in addition to standard-of-care treatments to improve COVID-19 outcomes, the agency says.
New wave of flu cases, COVID-19 hospitalizations hits U.S., impacting seniors
By
Alicia Lasek
Dec 06, 2022
Flu activity was the highest in a decade last week and hospitalizations for three respiratory viruses are straining healthcare systems, CDC Director Rochelle Walensky said on Monday.
National survey tells story of COVID in assisted living
By
Alicia Lasek
Aug 19, 2021
New industry data from the CDC’s National Center for Health Statistics details how COVID-19 affected assisted living communities across the country during the height of the pandemic.
Clinical briefs for Tuesday, Sept. 21
By
Alicia Lasek
Sep 21, 2021
Humana reports rise in seniors’ COVID hospitalizations … Moderna shot leads pack at preventing COVID hospitalization, CDC finds … Experts unsure what flu has in store for this season … Drug combo...
‘A different phase’: End of COVID-19 vax rule for healthcare workers
By
Alicia Lasek
May 02, 2023
A COVID-19 vaccination rule for healthcare workers that took full effect after a Supreme Court vote in early 2022 will soon be lifted, the Biden administration says.
WHO calls end to COVID-19 global health emergency
By
Alicia Lasek
May 08, 2023
It is time for the international community to recognize COVID-19 as an endemic disease and end the pandemic health emergency, the World Health Organization announced Friday.
COVID-19 antiviral drug trials expected to wrap up within months: report
By
Alicia Lasek
Sep 27, 2021
Clinical trials for new COVID-19 antiviral drugs are expected to wrap up by winter, sparking hopes that a daily pill to treat COVID-19 infection is closer to fruition, according to a new report.
Remdesivir cuts risk of severe COVID-19 by 87 percent in non-hospitalized patients
By
Alicia Lasek
Jan 21, 2022
The results suggest that remdesivir (brand name Veklury) could be used to treat outpatients early in the disease course, researchers say. The drug currently is authorized for use only in hospitalized COVID-19...
Symptomless COVID infections found in almost half of US adults, CDC says
By
Alicia Lasek
Dec 05, 2022
Approximately 44% of US adults were “possibly asymptomatically infected,” between August 2021 and May 2022, blood serum evidence shows.
COVID-19-related neuropsychiatric conditions mirror those of other respiratory illnesses, study finds
By
Alicia Lasek (f3)
May 12, 2022
Disease severity, not pathogen type, is key when treating neuropsychiatric complications after respiratory illness, a new study finds.